News
Moderna is set to receive $176 million in federal funding to develop a human vaccine against bird flu following outbreaks of the virus in dairy cows across several states, the Department of Health ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
According to the CDC, there has been a decline in animal infections and no reports of human cases since February.
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Short sellers started to panic in recent days. Moderna (MRNA), which has a short interest of 16.44%, might benefit from two ...
The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing.
MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results